Sarissa Capital Management as of March 31, 2024
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 10 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 25.0 | $143M | 16M | 8.71 | |
| Biogen Idec (BIIB) | 24.3 | $139M | 643k | 215.63 | |
| Innoviva (INVA) | 19.4 | $111M | 7.3M | 15.24 | |
| Gilead Sciences (GILD) | 14.1 | $81M | 1.1M | 73.25 | |
| Neurocrine Biosciences (NBIX) | 8.4 | $48M | 346k | 137.92 | |
| Amarin Corp Spons Adr New (AMRN) | 3.9 | $22M | 25M | 0.89 | |
| Cytokinetics Com New (CYTK) | 3.7 | $21M | 300k | 70.11 | |
| BioCryst Pharmaceuticals (BCRX) | 1.0 | $5.6M | 1.1M | 5.08 | |
| Vor Biopharma (VOR) | 0.3 | $1.5M | 618k | 2.37 | |
| Regulus Therapeutics (RGLS) | 0.1 | $533k | 185k | 2.88 |
